MARKET WIRECNBC • 2h ago
Here are 3 big things we're watching in the stock market in the week aheadThe market could use a few victories in the days ahead, which will be filled with more earnings, an election, and jobs data.
Why ALMR Stock slipped -0.76% Today — RQD Quant Desk Flash
$34.04 -0.76% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $33.93
Alamar Biosciences Inc. (ALMR) carries a Roarable Rating of D (Sell) with 48/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE D • SELL / AVOID
Cap $2.36B
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $33.93 (-0.33%)🧬 Disciplined Float (-0.40% YoY Shares)⚙️ Cash Engine: 10/20 (D) • 1.7% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record Warning: Scores below 50 (48/100 · D) historically underperformed SPY in 71% of rolling 90-day windows (-5.6% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →RQD QUANT TACHOMETERSELL / AVOID • D
2-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw D- · Rk D+
Each axis scored 0–20
12M PRICE TARGET CONE-4.5% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for ALMR)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (48/100 Composite)
🔍 WHY ALMR SCORES 48/100 (D) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+13/20 pts (27% of score)
Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9
▲ #2 Bullish Driver: Cash Engine Quality+10/20 pts (21% of score)
SEC XBRL FY 2025 (10-K): 1.7% FCF Margin ($66.1M FCF) & 52% Gross Margin
▼ #1 Drag / Risk Factor: Whale & Options Positioning6/20 pts (-14 pt drag)
Put hedging (50% put share) caps near-term gamma upside (-14 pts vs max)
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade D$25.27+0% Next Q
40
Q2 (-2Q)Grade D$25.28+21.4% Next Q
43
Q3 (-1Q)Grade D$30.69+10.9% Next Q
45
CurrentGrade D$34.04-5.6% Hist 90D α
48
Trajectory: D (40) → D (48)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER
⚔️ Adversarial Opposing Case: What Could Spark a ALMR Turnaround Squeeze
While ALMR currently carries a cautious 48/100 (D) rating due to Whale & Options Positioning (6/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
🚀 Contrarian Squeeze Trigger #1
Established market leader in Health Care with deep daily trading liquidity.
🚀 Contrarian Squeeze Trigger #2
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($30.65) and Max Pain ($35.74) forces dealer call-delta covering toward $41.59.
🚀 Contrarian Squeeze Trigger #3
Forensic Repair Trigger: Halting share dilution (Disciplined Float (-0.40% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
🎲 LIVE PREDICTION MARKET ODDS TIED TO $ALMR• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “ALMR Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why ALMR Stock slipped -0.76% Today — RQD Quant Desk Flash
Alamar Biosciences Inc. (ALMR) slipped -0.76% to $34.04, trading at 73% of its 52-week range ($18.85 – $39.61). Stretched risk/reward at current multiples (steady margins) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 73% of its 52-week range ($18.85 – $39.61) with RSI-14 at 50.8 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $34.04 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable D (Sell) backed by 52% gross margin and $66.1M annual free cash flow.
Live ALMR Headlines & Catalysts
MARKET WIRECNBC • 3h ago
Democratic Rep. Stevens endorses Rogers over El-Sayed in Michigan Senate electionHaley Stevens had lost the Democratic nomination for Senate in Michigan to Abdul El-Sayed earlier this year.
RISK WATCHReuters • 4h ago
Israeli strikes kill eight people in Gaza - medics say - ReutersIsraeli strikes kill eight people in Gaza - medics say Reuters
MARKET WIREReuters • 5h ago
Russia's FSB says minor detained over park attack threat after US tip-off - ReutersRussia's FSB says minor detained over park attack threat after US tip-off Reuters
MARKET WIREReuters • 6h ago
Iran, Qatari mediators hold third day of talks to end US-Iran war - ReutersIran, Qatari mediators hold third day of talks to end US-Iran war Reuters
CATALYSTReuters • 7h ago
Qatar surges, bucking Gulf market slide on Iran war concerns - ReutersQatar surges, bucking Gulf market slide on Iran war concerns Reuters
MARKET WIREReuters • 7h ago
OPEC+ keeps December oil output targets steady ahead of tougher call for 2027 - ReutersOPEC+ keeps December oil output targets steady ahead of tougher call for 2027 Reuters
MARKET WIREReuters • 7h ago
German ministers pledge tough action after rioters damage stores in Frankfurt - ReutersGerman ministers pledge tough action after rioters damage stores in Frankfurt Reuters
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring ALMR)
- ✓Walkthrough of ALMR's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
ALMR // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +35.94%▲ ASCENDING CHANNEL
2026-10-30O $33.35H $34.04L $29.36C $34.04VOL 740.0K
RES: $40.10SUP: $23.49SMA50: $30.65SMA200: $26.93
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
ALMR Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth
vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on ALMR today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for ALMR. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for ALMR today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (ALMR)
Health Care Rank #378 of 1016
⚔️ PACB vs ALMR Full Matrix →
1. Head-to-Head Health Care Peer Comparison (ALMR vs. PACB, CTKB, BRKR, BIO)
Industry: Biotechnology: Laboratory Analytical Instruments (21 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, Alamar Biosciences Inc. (ALMR) ranks #378 by composite RQD confidence (48/100, grade D) and #230 by equity capitalization ($2.36B). Within this direct 5-issuer industry benchmark cohort, BIO leads on earnings valuation at 13.5x trailing P/E, while BRKR leads on capital efficiency and profitability with 1.3% ROIC and 45.9% gross margin. BIO currently holds the highest overall quantitative score in the immediate peer group at 66/100 (C+) compared with ALMR at 48/100 (D).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| ALMR
ACTIVE
Alamar Biosciences Inc. | D | 48/100 | — | — | — | -0.76% | $2.36B | Benchmark Subject |
| PACB Pacific Biosciences of California Inc. | D- | 37/100 | — | 28.6% | -35.0% | +2.47% | $901.4M | /pacb-vs-almr → |
| CTKB Cytek Biosciences Inc. | D- | 41/100 | — | 51.8% | -12.7% | +2.61% | $818.9M | /ctkb-vs-almr → |
| BRKR Bruker Corporation | C- | 59/100 | — | 45.9% | 1.3% | 0.00% | $9.45B | /brkr-vs-almr → |
| BIO Bio-Rad Laboratories Inc. | C+ | 66/100 | 13.5x | 51.9% | 0.5% | -0.19% | $10.28B | /bio-vs-almr → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2025–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0002104204In its most recent audited fiscal period (FY2025, filed 2025-12-31), Alamar Biosciences Inc. (ALMR) reported GAAP revenue of $0 , GAAP net income of $0, operating cash flow of $0, and free cash flow of $0 . On the balance sheet, ALMR closed FY2025 with $140.0M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: N/A).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $0 | $0 | — | — | $140.0M | — |
3. ALMR Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs ALMR stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, Alamar Biosciences Inc. (NASDAQ: ALMR) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 48/100 at a spot price of $34.04 (-0.76% 1D, market cap $2.36B). Pillar breakdown: Fundamental Cash Engine 10/20, Institutional 13F & Options Flow 6/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 9/20. Across 1016 tracked Health Care issuers, ALMR ranks #378 in composite RQD confidence.
How does ALMR compare to PACB and CTKB in the Health Care sector?
Within the Health Care sector (Biotechnology: Laboratory Analytical Instruments), ALMR carries a Roarable D (48/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, PACB (Pacific Biosciences of California Inc.) holds a D- grade (37/100 RQD, P/E N/A, ROIC -35.0%, cap $901.4M) and CTKB (Cytek Biosciences Inc.) posts a D- grade (41/100 RQD, P/E N/A, ROIC -12.7%, cap $818.9M). Among the 5-stock peer group, BIO leads on earnings multiple (13.5x) while BRKR leads on capital efficiency (1.3% ROIC).
What are the biggest fundamental strengths and SEC risk factors for ALMR?
Per ALMR's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0002104204), Alamar Biosciences Inc. generated $0 in revenue, $0 in net income, and $0 in free cash flow against $140.0M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is ALMR trading relative to its 50-day, 200-day, and 52-week technical levels?
ALMR last traded at $34.04 (-0.76% on volume of 496,166 shares), positioning the stock +11.06% above its 50-day simple moving average ($30.65) and +26.40% above its 200-day simple moving average ($26.93). Across its 52-week range of $18.85 to $39.61, ALMR sits at the 73.2% percentile with a 14-day RSI of 50.8 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($29.79 to $38.29).
ALMR Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is ALMR stock moving today?
Why ALMR Stock slipped -0.76% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (steady margins) under elevated 10-year interest-rate pressure.